| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/14/2023 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Common Stock | 25k | $1.00 | $25k | | 07/14/2023 |
| 06/02/2023 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 2k | $11.41 | $22.4k | | 06/02/2023 |
| 05/22/2023 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 2.1k | $12.87 | $27.2k | | 05/22/2023 |
| 03/01/2023 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 2k | $8.53 | $17.3k | | 03/01/2023 |
| 01/19/2023 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Common Stock | 33k | $0.00 | $0 | | 01/19/2023 |
| 01/19/2023 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Stock Option (Right to Buy) | 55k | $8.35 | $459.2k | | 01/19/2023 |
| 11/21/2022 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 2.2k | $9.60 | $20.7k | | 11/21/2022 |
| 09/01/2022 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Common Stock | 7.5k | $0.00 | $0 | | 09/01/2022 |
| 05/19/2022 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Common Stock | 12k | $0.00 | $0 | | 05/19/2022 |
| 05/13/2022 | Phathom Pharmaceuticals, Inc. | PHAT | Purchase | Common Stock | 6k | $0.00 | $0 | | 05/13/2022 |
| 04/05/2022 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Common Stock | 20k | $0.00 | $0 | | 04/05/2022 |
| 04/05/2022 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Stock Option (Right to Buy) | 100k | $15.08 | $1.5M | | 04/05/2022 |
| 01/31/2022 | UroGen Pharma Ltd. | URGN | Sale | Ordinary Shares | 331 | $7.58 | $2.5k | | 01/31/2022 |
| 01/31/2022 | UroGen Pharma Ltd. | URGN | Exercise | Restricted Stock Units | 666 | $0.00 | $0 | | 01/31/2022 |
| 01/31/2022 | UroGen Pharma Ltd. | URGN | Grant | Restricted Stock Units | 7.5k | $0.00 | $0 | | 01/31/2022 |
| 01/31/2022 | UroGen Pharma Ltd. | URGN | Grant | Stock Option (right to buy) | 30k | $7.72 | $231.6k | | 01/31/2022 |
| 11/30/2021 | UroGen Pharma Ltd. | URGN | Exercise | Restricted Stock Units | 5k | $0.00 | $0 | | 11/30/2021 |
| 11/30/2021 | UroGen Pharma Ltd. | URGN | Sale | Ordinary Shares | 2.6k | $12.03 | $31.1k | | 11/30/2021 |
| 06/05/2021 | UroGen Pharma Ltd. | URGN | Grant | Stock Option (right to buy) | 15k | $17.98 | $269.7k | | 06/05/2021 |
| 05/17/2021 | UroGen Pharma Ltd. | URGN | Purchase | Common Stock | 2.5k | $15.85 | $39.6k | | 05/17/2021 |
| 01/31/2021 | UroGen Pharma Ltd. | URGN | Grant | Stock Option (right to buy) | 6k | $22.07 | $132.4k | | 01/31/2021 |
| 01/31/2021 | UroGen Pharma Ltd. | URGN | Grant | Restricted Stock Units | 2k | $0.00 | $0 | | 01/31/2021 |
| 10/01/2020 | UroGen Pharma Ltd. | URGN | Grant | Stock Option (Right to Buy) | 60k | $19.66 | $1.2M | | 10/01/2020 |
| 10/01/2020 | UroGen Pharma Ltd. | URGN | Grant | Restricted Stock Units | 15k | $0.00 | $0 | | 10/01/2020 |
| 05/04/2020 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Options | 50k | $0.66 | $33k | | 05/04/2020 |
| 10/24/2019 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Option | 25k | $0.31 | $7.8k | | 10/24/2019 |
| 04/11/2019 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Common Stock | 2.5k | $3.68 | $9.2k | | 04/11/2019 |
| 04/09/2019 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Common Stock | 100 | $3.85 | $385 | | 04/09/2019 |
| 04/09/2019 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Common Stock | 2.9k | $3.86 | $11.2k | | 04/09/2019 |
| 11/05/2018 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Option | 125k | $0.54 | $67.5k | | 11/05/2018 |
| 06/12/2018 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Common Stock | 5k | $1.89 | $9.4k | | 06/12/2018 |
| 06/06/2018 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Stock Option | 250k | $1.71 | $427.5k | | 06/06/2018 |
| 12/28/2015 | IOVANCE BIOTHERAPEUTICS, INC. | IOVA | Grant | Stock Option (right to buy) | 21.1k | $7.58 | $160.1k | | 12/28/2015 |
| 06/08/2015 | IOVANCE BIOTHERAPEUTICS, INC. | IOVA | Grant | Stock Option | 200k | $10.69 | $2.1M | | 06/08/2015 |
| 03/11/2010 | VirtualScopics, Inc. | VSCP | Purchase | stock option | 47.6k | $1.18 | $56.2k | | 03/11/2010 |
|